WHO Adds Two Cancer Drugs to Essential Medicines List

The World Health Organisation says the two recently developed immunotherapies - anivolumab and pembrolizumab - have delivered up to 50% survival rates for advanced melanoma, a cancer that until recently was incurable. WHO's Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritise critical health products that should be widely available and affordable throughout health systems.



Don't Miss

AllAfrica publishes around 800 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.